Your browser doesn't support javascript.
loading
Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
Quinet, Béatrice; Laudat, France; Gurtman, Alejandra; Patterson, Scott; Sidhu, Mohinder; Gruber, William C; Scott, Daniel A.
Affiliation
  • Quinet B; From the *Groupe Hospitalier Armand Trousseau-La Roche Guyon Consultation de Pédiatrie Générale et Aval des Urgences; †Pfizer Inc, Paris, France; ‡Pfizer Inc, Collegeville, PA; and §Pfizer Inc, Pearl River, NY.
Pediatr Infect Dis J ; 33(10): 1065-76, 2014 Oct.
Article in En | MEDLINE | ID: mdl-25093973

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Immunization, Secondary / Pneumococcal Vaccines / Antibodies, Bacterial Type of study: Observational_studies Limits: Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 2014 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Immunization, Secondary / Pneumococcal Vaccines / Antibodies, Bacterial Type of study: Observational_studies Limits: Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 2014 Document type: Article Country of publication: United States